Your browser doesn't support javascript.
loading
Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics.
Penel, Nicolas; Delord, Jean-Pierre; Bonneterre, Marie-Edith; Bachelot, Thomas; Ray-Coquard, Isabelle; Blay, Jean-Yves; Pascal, Laurent Benjamin; Borel, Cécile; Filleron, Thomas; Adenis, Antoine; Bonneterre, Jacques.
Affiliation
  • Penel N; Département de Cancérologie Générale, Centre Oscar Lambret, 3, Rue F Combemale, Lille, France. n-penel@o-lambret.fr
Invest New Drugs ; 28(1): 76-82, 2010 Feb.
Article in En | MEDLINE | ID: mdl-19205623
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Models, Statistical / Clinical Trials, Phase I as Topic / Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2010 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Models, Statistical / Clinical Trials, Phase I as Topic / Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 2010 Type: Article Affiliation country: France